1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)


SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

Cell lines tested with sirolimus:bortezomib (250:1 mol/mol)

852 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with sirolimus:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2163
large intestineCTRPv247
central nervous systemCTRPv246
Download CSV
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA TCF4 CTRPv2 AAC 0.23 3e-10
mRNA GGA2 CTRPv2 AAC 0.23 8e-10
mRNA RHOH CTRPv2 AAC 0.25 1e-09
mRNA CCDC117 CTRPv2 AAC 0.21 3e-09
mRNA POU2AF1 CTRPv2 AAC 0.23 3e-09
mRNA TOR3A CTRPv2 AAC 0.21 4e-09
mRNA IGF2BP2 CTRPv2 AAC -0.22 4e-09
mRNA FAM214A CTRPv2 AAC 0.21 7e-09
mRNA PIK3CB CTRPv2 AAC -0.19 1e-08
mRNA ZNF532 CTRPv2 AAC 0.21 2e-08
Download CSV